Manufacturers Life Insurance Company, The Pharvaris N.V. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Pharvaris N.V. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 44,878 shares of PHVS stock, worth $913,267. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,878
Previous 55,078
18.52%
Holding current value
$913,267
Previous $1.04 Million
19.71%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PHVS
# of Institutions
51Shares Held
39.6MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$153 Million3.99% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.4MShares$89.5 Million53.23% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$87.3 Million65.3% of portfolio
-
Viking Global Investors LP3.65MShares$74.3 Million0.26% of portfolio
-
Vr Adviser, LLC New York, NY3.4MShares$69.1 Million6.51% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $687M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...